evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

5 questions · 5 findings · 1 reviews

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 20%Low 4 · 80%Moderate 0 · 0%High 0 · 0%

Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins

Live birth rate per woman · ovulation induction in polycystic ovarian syndrome

Recombinant follicle stimulating hormone showed no clear difference in live birth rate per woman compared with urinary‐derived gonadotrophins (low certainty).

1 finding from 1 review

Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins

Multiple pregnancy rate · ovulation induction in polycystic ovarian syndrome

Recombinant follicle stimulating hormone showed no clear difference in incidence of multiple pregnancy (per woman) compared with urinary‐derived gonadotrophins (low certainty).

1 finding from 1 review

Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins

Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome

Recombinant follicle stimulating hormone showed no clear difference in clinical pregnancy rate per woman compared with urinary‐derived gonadotrophins (low certainty).

1 finding from 1 review

Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins

OHSS · ovulation induction in polycystic ovarian syndrome

It is very uncertain whether recombinant follicle stimulating hormone changes incidence of OHSS per woman compared with urinary‐derived gonadotrophins (very low certainty).

1 finding from 1 review